Advance Dx, Inc. recalls Advance Dx 100 Blood Collection Card Quantity 25 REF CMT01 Advance Dx 100 Blood Collection Card and Foil Bags Quantity…
- Recall date
- July 6, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2237-2021
- FDA classification
- Class II
- Brand / firm
- Advance Dx, Inc.
- Sold / distributed
- U.S. Nationwide distribution in the states of MD and NC.
Why it was recalled
Due to high glucose test results when using the blood collection cards.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Advance Dx 100 Blood Collection Card Quantity 25 REF CMT01 Advance Dx 100 Blood Collection Card and Foil Bags Quantity 500 Cards and Foil Bags REF CMT01/F02 IFU: Advance Dx 100 SSE(Serum Separating Extraction) Technology BLOOD COLLECTION INSTRUCTIONS
Get recall alerts
Free email alert whenever Advance Dx, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Advance Dx, Inc.